Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
BIO-key International ( (BKYI) ) has issued an update.
On May 9, 2025, BIO-key International received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share. Despite not regaining compliance by November 6, 2025, Nasdaq granted the company an additional 180 days, until May 4, 2026, to meet the requirement. The company plans to monitor its stock price and may implement a reverse stock split to maintain its Nasdaq listing.
The most recent analyst rating on (BKYI) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on BIO-key International stock, see the BKYI Stock Forecast page.
Spark’s Take on BKYI Stock
According to Spark, TipRanks’ AI Analyst, BKYI is a Neutral.
BIO-key International’s overall stock score is primarily impacted by its challenging financial performance and valuation concerns, with ongoing losses and negative cash flow. Despite positive developments in revenue growth and strategic contracts highlighted in the earnings call, the stock’s technical indicators suggest a bearish trend.
To see Spark’s full report on BKYI stock, click here.
More about BIO-key International
BIO-key International, Inc. operates in the technology industry, focusing on biometric authentication solutions. The company provides products and services that enhance security through fingerprint and other biometric technologies, catering to various sectors requiring secure access and identity verification.
Average Trading Volume: 4,452,813
Technical Sentiment Signal: Sell
Current Market Cap: $4.63M
For a thorough assessment of BKYI stock, go to TipRanks’ Stock Analysis page.

